Early Detection of Lung Cancer (NCT03181256)
Early Detection of Lung Cancer in the Medically Underserved Population
🩺 Plain-English Summary (8th-Grade Level)
This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (4 items).
Location: Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
Age range: 55 Years to 80 Years
🧪 Interventions in This Study
- Biospecimen Collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Pulmonary Function Test (PROCEDURE)
- Computed Tomography (CT) (PROCEDURE)
- Laboratory Biomarker (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- History of diagnosis/treatment of lung cancer in the past 2 years
- History of head/neck or esophageal cancer in the last 1 year
- Inability to provide informed consent
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Precision Lung Cancer Survivorship Care Intervention — Lexington, Kentucky
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Study of Trilaciclib and Lurbinectidin — Lebanon, New Hampshire
- Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT — Boston, Massachusetts
- Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer — Rochester, New York
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.